Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.0%

3 terminated/withdrawn out of 151 trials

Success Rate

96.6%

+10.1% vs industry average

Late-Stage Pipeline

27%

41 trials in Phase 3/4

Results Transparency

5%

4 of 85 completed trials have results

Key Signals

14 recruiting4 with results

Enrollment Performance

Analytics

N/A
46(43.4%)
Phase 4
25(23.6%)
Phase 3
16(15.1%)
Phase 2
12(11.3%)
Phase 1
7(6.6%)
106Total
N/A(46)
Phase 4(25)
Phase 3(16)
Phase 2(12)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (151)

Showing 20 of 151 trials
NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Role: collaborator

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT01460589Phase 3Active Not Recruiting

Early Commencement of Adjuvant Chemotherapy for Colon Cancer

Role: lead

NCT05673772Phase 2Active Not Recruiting

Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer

Role: lead

NCT03426904Phase 3Active Not Recruiting

Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

Role: lead

NCT07355153Not ApplicableCompleted

Feasibility of CALM Therapy in Korean Cancer Patients

Role: lead

NCT07265817Not ApplicableNot Yet Recruiting

Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms

Role: lead

NCT06868186Not ApplicableRecruiting

A Multicenter Study of RUS NE

Role: collaborator

NCT01282073Phase 3Completed

Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy

Role: lead

NCT06124833Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Role: collaborator

NCT04010955Active Not Recruiting

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

Role: collaborator

NCT07038226Not ApplicableCompleted

Fecal Microbiota Transplantation Via Oral Capsule for Treating Refractory Constipation in Parkinson's Disease

Role: collaborator

NCT03411096Not ApplicableCompleted

Quadratus Lumborum Block : Local Anesthesia Versus Placebo

Role: lead

NCT02026843Recruiting

Analysis of Biomarkers From Patients With Chorioretinal Diseases

Role: lead

NCT04718935Completed

Nutritional and Metabolic Biomarkers in Prediction of Outcomes After Traumatic Brain Injury: a Patient Cohort Study

Role: collaborator

NCT06218485Not ApplicableRecruiting

FFR Versus IVUS with Angiography-Derived FFR for Clinical Outcomes in Patients with Coronary Artery Disease

Role: collaborator

NCT06779695Active Not Recruiting

Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)

Role: collaborator

NCT05770687Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Role: collaborator

NCT02112214Phase 3Active Not Recruiting

Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population

Role: collaborator

NCT03753074Phase 4Active Not Recruiting

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

Role: collaborator